Literature DB >> 4813248

Measurement of drug displacement by continuous ultrafiltration.

D S Campion, R Olsen.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4813248     DOI： 10.1002/jps.2600630215

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  9 in total

1.  Factors affecting drug-protein binding in the plasma of newborn infants.

Authors:  S Wallace
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

2.  Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration.

Authors:  L J Lesko; P K Narang; L Yeager; N R Cutler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Protein binding of piretanide in normal and uraemic serum.

Authors:  H L Elliott; A F Ansari; B C Campbell; J R Lawrence
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  The protein binding of methotrexate by the serum of normal subjects.

Authors:  W H Steele; J R Lawrence; J F Stuart; C A McNeill
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

5.  Serum, tear and salivary concentrations of methotrexate in man.

Authors:  W H Steele; J F Stuart; B Whiting; J R Lawrence; K C Calman; J G McVie; G M Baird
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

6.  The influence of protein binding on disopyramide clearance.

Authors:  S M Bryson; J R Lawrence; W H Steele; B C Campbell; H L Elliott; D J Sumner
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Protein binding of salicylate in cutaneous hepatic porphyria.

Authors:  W H Steele; S W Boobis; M R Moore; A Goldberg; M J Brodie; D J Summer
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

8.  Alterations of phenytoin protein binding with in vivo haemodialysis in dialysis encephalopathy.

Authors:  W H Steele; J R Lawrence; H L Elliott; B Whiting
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

9.  The protein binding of methotrexate in the serum of patients with neoplastic disease.

Authors:  W H Steele; J R Lawrence; J F Stuart; C A McNeill
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.